Abstract: Pentacyclic triterpenes (PTs) as aglycones of saponins have a wide distribution in plants, and many of them have been used as anti-inflammatory remedies in folk medicine. This survey critically reviews the effects of PTs on proinflammatory mediator signalling pathways and data from experimental animal models and clinical trials. Because the knowledge of their actions is far from being satisfactory a critical summary of the partly promising but mostly scattered and preliminary data might promote productive research on chances and risks of PTs. Antiproliferative and anti-infectious actions and effects on intracellular cell signalling and hormone metabolism are beyond the scope of this short review, although such effects might also contribute to the understanding of the systemic anti-inflammatory actions of aglycones.
Introduction
In this review we present a survey on the antiphlogistic potential of a selected number of PTs ( Fig. 1) for which the observed anti-inflammatory actions can be rationalized by data from in vitro mechanistic studies. We mainly consider studies which were carried out with purified compounds. We also try to reflect the reasonableness ofthe concentrations used in vitro and structure-activity relationships as far as data are available. Effects of saponins or crude extracts are only discussed if they contribute to the understanding ofthe actions of PTs. Principles of anti-in flammatoty drug action Anti-inflammatory compounds can act on many steps of pathophysiological processes. For example, a compound might block the biosynthesis of proinflammatory mediators by direct interaction with a key enzyme (e.g., inhibition of cyclooxygenase-Il) or by decreasing enzyme expression (e.g., steroidal anti-inflammatory compounds) or by reducing substrate levels (e.g., decreased release of arachidonic acid).
Alternatively, or in addition, a compound can act by inhibiting the release of preformed, stored mediators (e.g., histamine release) or block mediator receptor interaction on target cells (e.g., leukotriene receptor antagonists). An anti-inflammatory compound may also act by immunostimulation (e.g., maturation of myeloid cells, stimulated phagocytosis) that in turn promotes an increased removal of the insulting signal molecules (organisms or, alternatively, by immunosuppression) that results in a less aggressive inflammatory response to allergen challenge. Thus, to evaluate the potential and the therapeutical index of a compound, qualified information on the mechanism and the selectivity of its action is needed.
PT Actions on Mediator Signalling Histamine release
Histamine is a preformed proinflammatory mediator stored in mast cells and basophilic granulocytes. Once released, it contracts smooth muscles of bronchi and gut, but powerfully relaxes those of small blood vessels. It promotes edema formation and stimulates gastric acid secretion and sensory nerve endings.
GA at concentrations from 20 to 35 pM, but not GL, inhibited dexamethasone induced increase in histamine content and histidine decarboxylase activity in mastocytoma P815 cells, and decreased histamine release from antigen stimulated rat mast cells (1). UA at concentrations of 1000pM or greater inhibited compound 48/80 induced histamine release from mast cells in vitro (2, 3). At 100pM UA was only a weak inhibitor (26%), whereas other tested triterpenoids (i.e., betulinic acid, 3-O-acetylbetulinic acid, betulinaldehyde and ursolaldehyde) exerted no significant effects (2).
Hydrolytic enzymes
Under physiological conditions, endogenous and host macromolecules are intracellularly degraded by controlled, cornpartmented hydrolytic enzyme activities. Increased secretion of stored proteolytic enzymes from stimulated proinflammatory cells occurs in the course of pathophysiological processes. This sustained extracellular enzyme activity impairs functionally relevant macromolecules such as structure proteins, glycoproteins, and polysaccharides. Hydrolytic activities are also involved in complex regulatory processes like the release of biologically active compounds from precursor proteins, activation of complement factors, and degradation/activation of signal molecules, hormones, and receptors. spectively (4). The pancreatic serine protease chymotrypsin was weakly inhibited by UA in vitro (K and IC50 values of 37 and 70 pM), but not by AKBA in concentrations up to 100pM (4,5). Application to rats of both the B. serrata gum resin and BA containing extracts thereof reduced glycosaminoglycan biosynthesis and degradation (7).
Strikingly, the gum resin was found to afford more therapeutic value than the BA extract in producing increased lysosomal stability and reduced fl-glucuronidase activity (8) . Effects on hyaluronidase of OA, hederagenin, and escinol were reported, but the IC50 values for this effect were exorbitantly high (6).
Effects of some PTs (e.g., OA ad BA5) on C3-convertase were observed but in these studies the inhibitors were used in concentrations greater than 200 pM (9, 10). A series of PTs inhibited immunohemolysis promoted by the classical complement pathway. Actions with IC50 values in the range of 10 to 5OpM were reported for UA, fl-BA, and crategolic acid, whereas GA and OA were less and fl-amyrin and friedelin were not inhibitory(1 1).
In the alternative pathway high concentrations of /3-BA (50 and 100pM) exerted anticomplementary activity, whereas UA, OA, crategolic acid, and GA were less active (11) . It was suggested that the effects of PTs on complement activation might be due to the inhibition of C3-convertase, which probably is the reflection of a more general inhibition of serine proteases (4, 11). From data of an early observation that the i. v. administration of GL induced an antiviral activity in mice serum, it was deduced that GL induced IFN, probably IFN?', production. GA promoted antiviral activity was more moderate and not dose-dependent (12) . GL increased in concentrations of 10 to 100 pg/mI (about 12 to 120pM) IFNy production in concanavalin A stimulated human peripheral lymphocyte-macrophage cocultures but not in resting cells (13). In GL treated cells RNA and protein synthesis were increased and the DNA synthesis was reduced. GL (200pg/ml, about 240pM) prolonged the duration of the growth response of T-lymphocytes, which were stimulated by anti-CD3 monoclonal antibody, concanavalin A, orA23187 plus PMA, along with increased IL-2 production and lL-2 receptor expression. Since GL did not modulate receptor mediated protein tyrosine phosphorylation or c-los transcription, it was suggested that the effect of GL is due to an interaction with a late step of the signal transduction pathway for lL-2 production (14). However, in immature thymocytes GL accelerated IL-2 production on the one hand and inhibited growth response on the other hand. These actions in immature cells were accompanied by an inhibition of tyrosine phosphorylation of p40 and c-los expression (15) .
Reactive oxygen species and lipid peroxidation in vitro
In viva, reactive oxygen species (ROS), such as NADPHoxidase-generated O' and enzymatic and non-enzymatic products from O are important factors of the cellular defence mechanisms in phagocytes. Substrate conversion by mono-and dioxygenases also contributes to the production of radicals and peroxides. A sustained overboarding production of radicals and peroxides may exhaust the capacity of endogenous scavengers and anti-oxidative mechanisms and lead to an impairment of functionally relevant structures. In in vitro and in viva assay systems radicals and peroxides are produced by chemical systems or by microsomal monooxygenase catalyzed metabolism of drugs.
GL (6OnM to 6aM) inhibited ROS generation in phagocytosing human neutrophils in vitro, but did not exert ROS scavenger activity in the xanthine/xanthine oxidase (XOD) system or impair neutrophil phagocytosis and chemotaxis (16 UA (at 1 pM), a dihemiphthalate of the oleanane series (IC50 = about 6pM), amyrin, amyrin derivatives and GA (producing 30% inhibition at 100 pM and with no effect at 10 pM) were reported to inhibit the conversion of exogenous substrate by 5-LO and/or COX (21 -24) . However, the data of these studies do not unambiguously demonstrate the inhibition of COX or 5-LO by these PTs. Thus, the postulated actions on prostaglandin and
Ieukotriene synthesis have to be confirmed by appropriate methods.
A BA containing crude extract and BAs, especially AKBA, inhibited 5-LO product formation from endogenous arachidonic acid in intact neutrophils, as well as from exogenous substrate in a ceIl-freee system and the activity of purified human 5-LO with IC50 values of 1.5pM, 8pM, and 15pM, respectively (18, 25, 26) . Many PTs (including UA, OA, amyrin), but not 4-ring compounds, bind to 5-LO protein. However, only PTs from the BA series possessing an Il-keto group in addition to a hydrophilic function at C-4 exert potent 5-LO inhibitory activity (26) (27) (28) . GA was reported to be active in ionophore-stimulated cells, although this action was attributed to inhibition of PLA2 (29) . In contrast, GA was found not to inhibit PG release from phagocytosing leukocytes (30) . In our hands, 18/3-GA exerted an LT biosynthesis inhibitory activity in intact neutrophils at higher concentrations (IC50 > 10pM), but the interpretation of its effect was hampered by a concomitant impairment of cell viability (19) . High concentrations of 18/3-GA also inhibited the conversion of exogenous arachidonic acid by 5-LO in cell-free systems by a competitive mechanism (observations not published).
In vivo, carbenoxolone treatment was associated with elevated gastric luminal concentrations of PGE2 in peptic ulcer patients (31) . It was suggested that carbenoxolone inhibits the activities of 15-hydroxy-PG-dehydrogenase and A13-PG-reductase and that the resulting decreased inactivation of cytoprotective PGs synthesized within the gastric mucosa contributes to the postulated ulcer healing effect of carbenoxolone (32, 33) . In addition, carbenoxolone inhibited the increased gastric mucosal release of LTC4, that was induced by intragastric installation of ethanol (34).
Experimental Animal Models
Systemic anti-inflammatory effects of PTs might be due to their actions on mediator signalling discussed so far. However, distinct irritants given, interaction with steroid hormone metabolism, kinases, phosphatases, virus replication and tumor cell proliferation, though not discussed in this short review, might also contribute to anti-inflammatory actions. Examples of such effects are the inhibition of 11 /3-HSD by GA in the nanomolar range and with less efficiency by OA (35-37), the inhibition of proteinkinases in the lower micromolar range by GA, UA, OA, and betulinic acid (38) , and the inhibition of virus replication by GA and betulinic acid derivatives (Fig. 3) (39, 40) .
Hepatoprotective activity Experimental hepatitis in animals is induced by different mechanisms. Heavy metals and toxic metabolites of drugs, the latter are radicals and peroxides generated by microsomal enzymes, impair hepatocytes directly whereas the effects of galactosamine (GaIN) and endotoxin (LPS) are promoted by inhibition of anabolic processes and activation of cellular defence mechanisms including immunological responses.
Oral administration of 18/3-GA, but not of GL, protected rats against GaIN induced increase in serum transaminases, whereas both GA and CL were active when administered i. p. (41) . GL in rats (i. v. or i.p.) had no protective effect on hepatic
injury induced by LPS but prevented the effects of Cd4 and allyl formate (42) .
A mixture of acetyl-BAs prevented GaIN and LPS induced liver damage in mice (43). Inhibition of HLE activity in addition to decreased formation of cysteinyl-LTs has been suggested to be the rationale for liver protection by BAs (5). OA protected rats against CCI4-induced acute liver injury (44) and CCI4/alcoholinduced cirrhosis (45) and CF-I mice against hepatotoxic effects of CCI4, acetaminophen, cadmium, bromobenzene, thioacetamide, furosemide, phalloidin, colchicine, GaIN, and LPS, but was ineffective against allyl alcohol (46, 47) . Protection against acetaminophen was not evident until 24 h after s. c. injection of OA and lasted for 72 h (48). It was suggested that OA decreases the formation of toxic metabolites of acetaminophen and increases detoxication since in mice OA suppressed liver microsomal cytochrome P450 isoenzymes CYP1A and CYP2A and increased hepatic content of metallothionein (49,50). Substantial protective effects against CCI4-, acetaminophen-, and Cd-induced liver injury were also observed with a-hederin and UA. Uvaol protected against CC14 and Cd-induced hepatotoxicity, GL, a-GA, and /3-GA against acetaminophen, whereas hederagenin and 19a-hydroxyasiatic acid did not protect against any of the toxicants (51).
Acute inflammatoiy animal models Anti-inflammatory effects in animal models were reported for a number of PTs. Most frequently the increase in paw volume of rats or mice in response to injection or implantation of irritants (carrageenan, dextran, cotton pellets, formaldehyde, serotonin, bacteria, etc.) has been measured. Since edema generation is most prominently promoted by proinflammatoiy PGs direct and indirect COX-Il inhibitors (steroidal and nonsteroidal antiinflammatory drugs) are often used as model compounds in these tests. It is noteworthy that many prointlammatory cytokines as well as many chemical and biological irritants upregulate COX-Il expression.
GA and derivatives (30, 52) , OA (53), betulin, betulinic acid, UA (54), and a crude BA containing extract from B. serrata gum resin (10, 55, 56) were reported to inhibit experimental edema in animals. Strikingly, the inhibitory effects of betulin, betulinic acid, and UA in carrageenan and serotonin paw edema tests could be blocked by progesterone, actinomycin D, and cycloheximide (54) suggesting that the anti-inflammatory actions of Immunomodulation Saikogenin D, as well as saikosaponin a and d, augmented nonspecific protection in mice against Pseudomonas aerugrnosa infection in terms of increased survival (63) . Soyasapogenol E (Fig. 4) was demonstrated to inhibit TPA induced EpsteinBarr virus early antigen activation (64) . A crude ethanolic extract of B. carterii gum resin decreased mortality in mice to which a suspension of E. coli had been administered intraperitoneally (65) . This in vivo observation was suggested to be due to stimulated phagocytic activity by the lipophilic nonsaponifiable fraction. A nonstandardized BA containing extract displayed either immunosuppressive or immunomodulating actions in mice depending on the dosage schedules and timings of administration in relation to antigen stimulation, whereas a preincubation of peritoneal macrophages at concentrations from 15 to 62 pg/mI stimulated the phagocytic activity in vitro (66) .
Clinical Studies
The GA derivative carbenoxolone has been used as an antiulcerative drug (for monographs see 67, 68). In Japan, a preparation of CL combined with glycine and cysteine has been widely used as an antihepatitis drug. Hematological and histological improvement following commencement of GL has been reported in patients with chronic hepatitis (for references see 12) . Since CL was observed to inhibit virus growth and to promote inactivation of virus particles (40) , it was also used for the prevention of recurrence of hepatitis B after liver transplantation (69) . However, the therapeutic index of GA and derivatives is limited due to potent mineralocorticoid actions, which are mediated by interaction with steroid metabolism.
OA has been marketed in China as an oral drug for human liver disorders and was reported to have been used successfully (for review see 70 
Summary and Perspectives
There are many reports on biological actions of P1's, which could be relevant for pharmacological effects including their anti-inflammatory properties. Data from in vitro studies could help to understand the mechanisms of their actions. It is, however, remarkable that many observations reported were obtained in studies using exorbitantly high concentrations. Because of the limited solubility and nonselective actions of high concentrations of lipophilic compounds the interpretation of the results must be critically reconsidered in order to evaluate the practical implications of a probable use in vivo. In summary, we suggest that in vitro effects produced with concentrations much greater than 10pM will hardly have a practical relevance. But there are reports also on highly interesting actions for a limited number of PTs at reasonable concentrations in vitro, which may help to explain pharmacological actions and side effects in vivo. In general, however, the current knowledge on effects of PTs and structure-activity relationships is preliminary. In conclusion, there exists promising data suggesting that PTs are a class of compounds with highly interesting biological effects worth to be studied more carefully. The low acute toxicity of these natural compounds and hints from SAR studies, which suggest that defined substitutents on the lipophilic 5-ring backbone can increase selectivity and potency of a desired action, indicate that PTs might provide a rich natural resource of lead compounds for drug development.
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